Mesenchymal Stem Cell Therapy for Osteoarthritis from China
Mesenchymal stem cell therapy for osteoarthritis consists of allogeneic MSCs derived from umbilical cord tissue, expanded and cryopreserved for intra-articular injection. This product is a cell therapy product under tariff item 3002.51.00, as it involves modified cell cultures for therapeutic use.
Duty Rate — China → Canada
0%
Import Tips
• Ensure the product is classified as a cell therapy product and not as a medicament under heading 30.04
• Provide documentation of the cell source and expansion process to CBSA
• Verify compliance with Health Canada's regulations for allogeneic cell therapies